Low levels of low-density lipoprotein cholesterol: A negative predictor of survival in elderly patients with advanced heart failure

Cardiology (Switzerland)

Volumn 127, Issue 1, 2013, Pages 45-50

  Charach, Gideon ^a   Rabinovich, Alexander ^a   Ori, Argov ^a   Weksler, Dov ^b   Sheps, David ^b   Charach, Lior ^a   Weintraub, Moshe ^a   George, Jacob ^c  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Cholesterol; Heart failure; Low density lipoprotein

Indexed keywords

ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE;

AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; FEMALE; FOLLOW UP; GERIATRIC DISORDER; HEART FAILURE; HUMAN; ISCHEMIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; NEW YORK HEART ASSOCIATION CLASS; PRIORITY JOURNAL; SURVIVAL; SYSTOLIC DYSFUNCTION; TRIACYLGLYCEROL BLOOD LEVEL; VERY ELDERLY; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE CLEARANCE; DISEASE DURATION; DISEASE SEVERITY; ELDERLY CARE; HYPERLIPIDEMIA; HYPERTENSION; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PREDICTOR VARIABLE; SURVIVAL RATE;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CARDIOTONIC AGENTS; CHOLESTEROL, LDL; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; PROGNOSIS; SURVIVAL RATE;

EID: 84890947833     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000355164     Document Type: Article

References (28)

1. Lenfant C: Report of the Task Force on Research in Heart Failure. Circulation 1994; 90: 1118-1123.
2. Cowie MR, Mosterd A, Wood DA, et al: The epidemiology of heart failure. Eur Heart J 1997; 18: 208-225.
3. Ford I, Murray H, Packard CJ, Shepherd J, et al: West of Scotland Coronary Prevention Study Group. Long-term follow-up of the West of Scotland Coronary Prevention Study. N Engl J Med 2007; 357: 1477-1486.
4. Pedersen TR, Olsson AG, Faergeman O, et al, Scandinavian Simavastatin Survival Study Group: Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994. Atherosclerosis 2004; 5(suppl):81-87.
5. Raina A, Pickering T, Shimbo D: Statin use in heart failure: a cause for concern? Am Heart J 2006; 152: 39-49.
6. van der Harst P, Voors AA, van Gilst WH, et al: Statins in the treatment of chronic heart failure: biological and clinical considerations. Cardiovasc Res 2006; 71: 443-454.
7. Song XJ, Yang CY, Liu B, et al: Atorvastatin inhibits myocardial cell apoptosis in a rat model with post-myocardial infarction heart failure by downregulating ER stress response. Int J Med Sci 2011; 8: 564-572.
8. Khush KK, Waters DD: Effects of statin therapy on the development and progression of heart failure: mechanisms and clinical trials. J Card Fail 2006; 12: 664-674.
9. Sakatani T, Shirayama T, Suzaki Y, et al: The association between cholesterol and mortality in heart failure. Comparison between patients with and without coronary artery disease. Int Heart J 2005; 46: 619-629.
10. von Haeling S, Okonko DO, Anker SD: Statins: a treatment option for chronic heart failure? Heart Fail Monit 2004; 4: 90-97.
11. Domanski M, Coady S, Fleg J, et al: Effect of statin therapy on survival in patients with nonischemic dilated cardiomyopathy (from the Beta-blocker Evaluation of Survival Trial [BEST]). Am J Cardiol 2007; 99: 1448-1450.
12. Iwaoka M, Obata JE, Abe M, et al: Association of low serum levels of apolipoprotein A-I with adverse outcomes in patients with nonischemic heart failure. J Card Fail 2007; 13: 247-253.
13. Afsarmanesh N, Horwich TB, Fonarow GC: Total cholesterol levels and mortality risk in nonischemic systolic heart failure. Am Heart J 2006; 152: 1077-1083.
14. Christ M, Klima T, Grimm W, et al: Prognostic significance of serum cholesterol levels in patients with idiopathic dilated cardiomyopathy. Eur Heart J 2006; 27: 691-699.
15. Horwich TB, Hamilton MA, Maclellan WR, et al: Low serum cholesterol is associated with marked increase in mortality in advanced heart failure. J Card Fail 2002; 8: 216-224.
16. Rauchhaus M, Clarc AL, Doehner W, et al: The relationship between cholesterol and survival in patients with chronic heart failure. J Am Coll Cardiol 2003; 42: 1933-1940.
17. Flammer AJ, Sudano I, Wolfrum M, et al: Cardiovascular effects of flavanol-rich chocolate in patients with heart failure. Eur Heart J 2012; 33: 2172-2180.
18. Silva S, Lourenço P, Paulo C, et al: Statin-induced low cholesterol is not associated with poor outcome in chronic heart failure. J Cardiovasc Pharmacol Ther 2012; 17: 284-290.
19. Aronov SW, Ahn C: Frequency of congestive heart failure in older persons with prior myocardial infarction and serum low-density lipoprotein cholesterol > or = 125 mg/dl treated with statins versus no lipid-lowering drug. Am J Cardiol 2002; 90: 147-149.
20. Richartz BM, Radovancevic B, Frazier OH, et al: Low serum cholesterol levels predict high perioperative mortality in patients supported by left ventricular assist system. Cardiology 1998; 89: 184-188.
21. Fraunberger P, Nagel D, Walli AK, et al: Serum cholesterol and mortality in patients multiple organ failure. Crit Care Med 2000; 28: 3574-3575.
22. Liu Y, Caresh J, Eustace JA, et al: Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition. JAMA 2004; 291: 451-459.
23. Schatz U, Masaki K, Yano K, et al: Cholesterol and all-cause mortality in elderly people from Honolulu Heart Program: a cohort study. Lancet 2001; 358: 351-355.
24. Tikhonoff V, Casiglia E, Mazza A, et al: Lowdensity lipoprotein cholesterol and mortality in older people. J Am Geriatr Soc 2005; 53: 2159-2164.
25. Anand IS, Latini R, Florea VG, et al, Val-HeFT Investigators: C-reactive protein in heart failure: prognostic value and effect of valsartan. Circulation 2005; 112: 1428-1434.
26. Charach G, George J, Afek A, et al: Baseline low-density lipoprotein cholesterol levels and outcome in patients with heart failure. Am J Cardiol 2010;105: 100-104.
27. Harris HW, Grunfeld C, Feingold KR, et al: Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice. J Clin Invest 1990; 86: 696-702.
28. Kjekshus J, Apetrei E, Barrios V, et al, CORONA Group: Rosuvastatin in older patients with systolic heart failure. NEJM 2007; 357: 1-14.